Guidelines for the use of botulinum toxin in movement disorders and spasticity
- PMID: 21847327
- PMCID: PMC3152173
- DOI: 10.4103/0972-2327.83099
Guidelines for the use of botulinum toxin in movement disorders and spasticity
Conflict of interest statement
References
-
- Simpson LL. Identification of the major steps in Botulinum toxin action. Ann Rev Pharmacol Toxicol. 2004;44:167–93. - PubMed
-
- Girlanda P, Quartarone A, Sinicropi S, Nicolosi C, Messina C. Unilateral injection of botulinum toxin in blepharospam: Single fiber electromyography and blink reflex study. Mov Disord. 1996;11:27–31. - PubMed
-
- Jankovic J, Orman J. Botulinum A toxin for cranial-cervical dystonia: A double-blind, placebo-controlled study. Neurology. 1987;37:616–23. - PubMed
-
- Nussgens Z, Roggenkamper P. Comparison of two Botulinum-toxin preparations in the treatment of essential blepharospasm. Gracfes Arch Clin Exp Ophthalmol. 1997;235:197–9. - PubMed
-
- Sampaio C, Ferreira JJ, Simões F, Rosas MJ, Magalhães M, Correia AP, et al. DYSBOT: A single-blind, randomized parallel study to determine w4hether any differences can be detected in the efficacay and tolerability of two formulations of botulinum toxin type A-Dysport and Botox - assuming a ratio of 4:1. Mov Disord. 1997;12:1013–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
